Breaking news Moderna soars 8% premarket on cancer vaccine results Dicembre 13, 2022 Moderna shares jumped more than 8% in Tuesday’s premarket session on news that a study of Moderna and Merck’s mRNA-based cancer vaccine showed promising results. The two firms said the combin…
